Skip to main content

Metabolon to Study Biofuel Metabolites for LS9

NEW YORK (GenomeWeb News) – The metabolomics-focused biomarker company Metabolon said on Tuesday that it has secured an agreement to test materials for the hydrocarbon biofuels developer LS9.
 
Metabolon said it will use its biochemical profiling service to identify changes in metabolites that occur during hydrocarbon biofuel production.
 
The focus will be to help LS9 optimize cellular metabolism in its Renewal Petroleum production process.
 
"As interest in the use of metabolomics has continued to grow, we have seen increased uptake from industry sectors like biofuel production," Metabolon CEO John Ryals said in a statement.
 
LS9’s technological aims are “well suited” for Metabolon’s biochemical profiling technology because it helps to provide “a picture of the reactions taking place at a biochemical level,” Ryals said.
 
Having that kind of a picture can have “an immediate and measurable impact on the fermentation processes,” Ryals added, which in turn “creates significant return in greater production and lowered cost.”
 
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.